410 ILCS 416/25
Reimbursement requirements; notice
Illinois · Illinois Compiled Statutes 410 ILCS 416 — Clinical Trial Participation Program Act. · Status: effective
Cite this
- Citation
- 410 ILCS 416/25, Reimbursement requirements; notice, Illinois, version 1 as recorded 2026-08-15, yourstate.us, https://yourstate.us/provision/1292785
- Permanent ID
ys:prov:1292785@1- SHA-256
656b27bac79a5554bd8c2a971c4919b2ccab62a33617ce8493aeba957e386336
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
Reimbursement requirements; notice.
(a) A reimbursement under the program at a trial site that conducts clinical trials must:
(1) be reviewed and approved by the institutional review board associated with the clinical trial for which the reimbursement is provided; and (2) comply with applicable federal and State laws.
(b) The independent third-party organization operating the program is not required to obtain approval from an institutional review board with respect to the financial eligibility of a subject who is medically eligible for a clinical trial.
(c) The independent third-party organization operating the program shall provide written notice to a subject on:
(1) the nature, availability, and scope of the ancillary financial support under the program; and (2) the program's general guidelines on financial eligibility. (Source: P.A. 103-227, eff. 6-30-23.)